M/S. Nicholas Piramal India Ltd. v. Commnr. of Central Excise, Mumbai

Court

Supreme Court of India

Decided

29 November 2010

Case no.

C.A. No.-005829-005829 - 2002

Bench

Mukundakam Sharma,Anil R. Dave

Facts

The appellant, M/s. Nicholas Piramal India Ltd., is engaged in the manufacture of Vitamin A and animal feed supplements. The case arose from five show cause notices issued to the appellant regarding the excise duty on "Vitamin A Acetate Crude" and "Vitamin A Palmitate," which were used in the production of animal feed supplements. The Commissioner confirmed the liability for excise duty on these products, asserting that they are commercially known and marketable, despite their unstable nature at room temperature.

Arguments

Petitioner Arguments

The petitioner argued that the products in question were not marketable and thus should not be subject to excise duty. They contended that the instability of the products at room temperature excluded them from being considered commercially viable. The court, however, countered this argument by emphasizing that commercial marketability does not solely depend on stability but also on recognition in the market and the existence of a distinct commercial identity.

Respondent Arguments

The respondent, the Commissioner of Central Excise, argued that "Vitamin A Acetate Crude" and "Vitamin A Palmitate" are distinct commercial entities and are covered under the Central Excise Tariff Act, 1985. The respondent pointed out that the products are recognized in pharmacopoeias and have a defined commercial identity, which supports their classification as excisable goods. The court agreed with this perspective, reinforcing the notion that marketability is not negated by the lack of sales or standard specifications.

Precedents considered

The judgment did not explicitly cite prior case law but relied on established legal principles regarding the definition of excisable goods and the interpretation of commercial marketability. The court's reasoning was grounded in the statutory framework of the Central Excise Act and the Tariff Act.

Legal principles

The court considered the following legal principles

• Commercial Marketability: A product can be considered excisable if it is recognized as commercially marketable, regardless of its stability or sales history.
• Tariff Classification: The classification of goods under the Central Excise Tariff Act is crucial in determining excise duty liability. The products in question fell under the heading for vitamins and provitamins.

Decision and reasoning

Rationale

The court's rationale centered on the definition of marketability and the statutory provisions of the Central Excise Act. It highlighted that the mere fact that the products were not sold did not exclude them from being commercially viable. The court also noted that the products had distinct identities in the market, which justified their classification as excisable goods.

Outcome

The Supreme Court upheld the CEGAT's decision, confirming that "Vitamin A Acetate Crude" and "Vitamin A Palmitate" are subject to excise duty. The court did not provide specific instructions for the appeal process, as the judgment was in favor of the respondent.

Conclusion

This judgment reinforces the principle that commercial viability and market recognition are key factors in determining excise duty liability. It clarifies that products, even in crude forms, can be subject to excise duty if they are recognized in the market, thereby impacting future cases involving similar classifications.

Read the full judgment on the Supreme Court website (PDF)